SPDR S&P Biotech ETF $XBI Shares Newly Purchased by National Wealth Management Group LLC

National Wealth Management Group LLC acquired a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,861 shares of the exchange traded fund’s stock, valued at approximately $609,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Bank of America Corp DE boosted its holdings in shares of SPDR S&P Biotech ETF by 13.3% during the first quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock worth $1,854,388,000 after purchasing an additional 1,700,851 shares during the period. Main Street Research LLC grew its stake in shares of SPDR S&P Biotech ETF by 57.4% in the first quarter. Main Street Research LLC now owns 567,479 shares of the exchange traded fund’s stock worth $72,484,000 after purchasing an additional 206,953 shares during the last quarter. Strs Ohio grew its stake in shares of SPDR S&P Biotech ETF by 4.9% in the first quarter. Strs Ohio now owns 410,500 shares of the exchange traded fund’s stock worth $52,433,000 after purchasing an additional 19,300 shares during the last quarter. Northwestern Mutual Wealth Management Co. increased its holdings in SPDR S&P Biotech ETF by 145.7% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 314,224 shares of the exchange traded fund’s stock valued at $49,726,000 after purchasing an additional 186,314 shares during the period. Finally, Annex Advisory Services LLC increased its holdings in SPDR S&P Biotech ETF by 4.6% during the 3rd quarter. Annex Advisory Services LLC now owns 266,485 shares of the exchange traded fund’s stock valued at $42,019,000 after purchasing an additional 11,723 shares during the period.

SPDR S&P Biotech ETF Price Performance

XBI opened at $150.47 on Tuesday. The business has a 50 day simple moving average of $157.13 and a two-hundred day simple moving average of $140.94. The firm has a market capitalization of $10.50 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a one year low of $106.30 and a one year high of $169.89.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.